Chargement en cours...

Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target

Dalbavancin is a novel lipoglycopeptide with activity against Staphylococcus aureus, including glycopeptide-resistant isolates. The in vivo investigation reported here tested the effects of this antibiotic against seven S. aureus isolates with higher MICs, including several vancomycin-intermediate s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Lepak, A., Marchillo, K., VanHecker, J., Andes, D.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649188/
https://ncbi.nlm.nih.gov/pubmed/26392492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01717-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!